NEW YORK (GenomeWeb News) – Vermillion today said that it has renewed a long-standing collaboration with Johns Hopkins University to develop biomarkers that can be potentially used as molecular diagnostics for cancer.
 
Under the terms of the agreement, Vermillion will have access to exclusive commercial rights to any discoveries from the partnership. Other terms of the alliance were not disclosed.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.